RedHill Biopharma Announces Presentation on YELIVA® (opaganib) for Multiple Myeloma at EORTC-NCI-AACR Symposium

Stock Information for Redhill Biopharma Ltd.

Loading

Please wait while we load your information from QuoteMedia.